Rallybio

This study followed over 14,000 pregnant women to see how often they develop a specific antibody (HPA-1a) that can lead to a rare but serious bleeding condition in newborns called FNAIT. The goal was to learn more about which women are at higher risk, especially across different …

This early-stage study tested the safety and how the body handles a new drug called RLYB116 in 16 healthy adults aged 18 to 55. Participants received multiple doses, and researchers monitored side effects, drug levels, and immune reactions. The goal was to gather safety informati…